XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Shares
Common Stock
Preferred Stock
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Treasury Stock
Beginning balance, shares (in shares) at Jun. 30, 2019     76,315,000       (12,604,000)
Beginning balance at Jun. 30, 2019 $ 1,133,209   $ 382,423   $ (24,221) $ 943,581 $ (168,574)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based and deferred compensation activities (in shares)     (708,000)       (251,000)
Share-based and deferred compensation activities (49,211)   $ 59,043       $ (9,832)
Shares issued and related to Finisar acquisitions (in shares)     26,713,000        
Shares issued related to Finisar acquisition 987,707   $ 987,707        
Net earnings (loss) (25,998)         (25,998)  
Foreign currency translation adjustments (13,019)       (13,019)    
Pension adjustment, net of taxes 84       84    
Ending balance, shares (in shares) at Sep. 30, 2019     103,736,000       (12,855,000)
Ending balance at Sep. 30, 2019 2,131,194   $ 1,429,173   (37,156) 917,583 $ (178,406)
Beginning balance, shares (in shares) at Jun. 30, 2019     76,315,000       (12,604,000)
Beginning balance at Jun. 30, 2019 1,133,209   $ 382,423   (24,221) 943,581 $ (168,574)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) (118,290)            
Foreign currency translation adjustments (28,258)            
Change in fair value of interest rate swap, net of taxes (27,798)            
Pension adjustment, net of taxes (167)            
Ending balance, shares (in shares) at Mar. 31, 2020     104,278,000       (13,103,000)
Ending balance at Mar. 31, 2020 2,017,907   $ 1,459,354   (80,444) 825,291 $ (186,294)
Beginning balance, shares (in shares) at Sep. 30, 2019     103,736,000       (12,855,000)
Beginning balance at Sep. 30, 2019 2,131,194   $ 1,429,173   (37,156) 917,583 $ (178,406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based and deferred compensation activities (in shares)     (307,000)       (175,000)
Share-based and deferred compensation activities (6,393)   $ 12,007       $ (5,614)
Common stock repurchase (in shares)             (50,000)
Common stock repurchase (1,625)           $ (1,625)
Net earnings (loss) (98,213)         (98,213)  
Foreign currency translation adjustments 24,590       24,590    
Change in fair value of interest rate swap, net of taxes 3,609       3,609    
Pension adjustment, net of taxes (251)       (251)    
Ending balance, shares (in shares) at Dec. 31, 2019     104,043,000       (13,080,000)
Ending balance at Dec. 31, 2019 2,065,697   $ 1,441,180   (9,208) 819,370 $ (185,645)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based and deferred compensation activities (in shares)     (235,000)       (23,000)
Share-based and deferred compensation activities (17,525)   $ 18,174       $ (649)
Net earnings (loss) 5,921         5,921  
Foreign currency translation adjustments (39,829)       (39,829)    
Change in fair value of interest rate swap, net of taxes (31,407)       (31,407)    
Pension adjustment, net of taxes 0            
Ending balance, shares (in shares) at Mar. 31, 2020     104,278,000       (13,103,000)
Ending balance at Mar. 31, 2020 2,017,907   $ 1,459,354   (80,444) 825,291 $ (186,294)
Beginning balance, shares (in shares) at Jun. 30, 2020     105,916,000 0     (13,356,000)
Beginning balance at Jun. 30, 2020 2,076,803   $ 1,486,947 $ 0 (87,383) 876,552 $ (199,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based and deferred compensation activities (in shares)     (575,000)       (120,000)
Share-based and deferred compensation activities $ (11,266)   $ 16,764       $ (5,498)
Shares issued (in shares) 10,698,000     2,300,000      
Shares issued in underwritten public offering $ 883,908   $ 438,589 $ 445,319      
Net earnings (loss) 46,266         46,266  
Foreign currency translation adjustments 35,524       35,524    
Change in fair value of interest rate swap, net of taxes (555)       (555)    
Dividends (6,535)         (6,535)  
Ending balance, shares (in shares) at Sep. 30, 2020     117,189,000 2,300,000     (13,476,000)
Ending balance at Sep. 30, 2020 3,046,677   $ 1,942,300 $ 445,319 (52,414) 916,283 $ (204,811)
Beginning balance at Jun. 30, 2020 0            
Beginning balance, shares (in shares) at Jun. 30, 2020     105,916,000 0     (13,356,000)
Beginning balance at Jun. 30, 2020 2,076,803   $ 1,486,947 $ 0 (87,383) 876,552 $ (199,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 215,258            
Foreign currency translation adjustments 81,191            
Change in fair value of interest rate swap, net of taxes 10,693            
Pension adjustment, net of taxes 0            
Ending balance, shares (in shares) at Mar. 31, 2021     118,370,000 2,300,000     (13,490,000)
Ending balance at Mar. 31, 2021 3,325,148   $ 2,011,210 $ 445,319 4,501 1,071,362 $ (207,244)
Beginning balance at Jun. 30, 2020 0            
Mezzanine Equity              
Accretion to redemption value of Series B shares issued in March 2021   $ 9          
Ending balance (in shares) at Mar. 31, 2021   75,000          
Ending balance at Mar. 31, 2021 716,200 $ 716,200          
Beginning balance, shares (in shares) at Sep. 30, 2020     117,189,000 2,300,000     (13,476,000)
Beginning balance at Sep. 30, 2020 3,046,677   $ 1,942,300 $ 445,319 (52,414) 916,283 $ (204,811)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based and deferred compensation activities (in shares)     (854,000)       (11,000)
Share-based and deferred compensation activities (42,215)   $ 43,533       $ (1,318)
Net earnings (loss) 87,900         87,900  
Foreign currency translation adjustments 64,067       64,067    
Change in fair value of interest rate swap, net of taxes 2,854       2,854    
Dividends (6,900)         (6,900)  
Ending balance, shares (in shares) at Dec. 31, 2020     118,043,000 2,300,000     (13,487,000)
Ending balance at Dec. 31, 2020 3,236,813   $ 1,985,833 $ 445,319 14,507 997,283 $ (206,129)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based and deferred compensation activities (in shares)     (327,000)       (3,000)
Share-based and deferred compensation activities $ (24,262)   $ 25,377       $ (1,115)
Shares issued (in shares)   75,000          
Common stock repurchase (in shares) 0            
Accretion to redemption value of Series B shares issued in March 2021 $ (9)         (9)  
Net earnings (loss) 81,092         81,092  
Foreign currency translation adjustments (18,400)       (18,400)    
Change in fair value of interest rate swap, net of taxes 8,394       8,394    
Pension adjustment, net of taxes 0            
Dividends (7,004)         (7,004)  
Ending balance, shares (in shares) at Mar. 31, 2021     118,370,000 2,300,000     (13,490,000)
Ending balance at Mar. 31, 2021 3,325,148   $ 2,011,210 $ 445,319 $ 4,501 $ 1,071,362 $ (207,244)
Mezzanine Equity              
Series B shares issued in March 2021   $ 716,087          
Dividends (in shares)   0          
Dividends   $ 104          
Ending balance (in shares) at Mar. 31, 2021   75,000          
Ending balance at Mar. 31, 2021 $ 716,200 $ 716,200